Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
102.20    10.80 (11.82%)
Bid:
102.20
Ask:
102.60
Spread: 0.40 (0.391%)
Market Cap: £429.60m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

TRADING UPDATE

Today 07:00

RNS Number : 5558I
PZ CUSSONS PLC
17 June 2026
 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

17 June 2026

TRADING UPDATE

Continued strong trading

Upgrade to FY26 profit guidance

 

PZ Cussons plc ("PZ Cussons" or "the Group") today issues a trading update for the year ended 31 May 2026.

 

The Group expects to report like for like revenue growth of c.6% for FY26, with reported revenue of c.£540 million. Performance continues to be broad-based, with growth across each of our four lead markets.

 

Reflecting continued strong trading and ongoing stability in the Nigerian Naira, the Group now expects to report FY26 adjusted Operating Profit at, or slightly above, the upper end of the previously guided range of £53-57 million. This compares to an initial guidance range of £48-53 million provided at the start of the financial year.

 

Net debt is expected to be less than £30 million[1]. This represents a reduction of over £80 million compared to FY25, driven primarily by the sale of the 50% stake in the PZ Wilmar joint venture. In addition, the financial guardrails which management are embedding to mitigate volatility in Nigeria have continued to reduce the Group's sensitivity to future movements in the Naira.

 

Looking ahead to FY27, the Group is mindful of the potential impact of the conflict in the Middle East and has already taken actions which are expected to offset a large majority of any cost inflation.

 

The Group will report FY26 results on 6 August 2026.

Contact details

 

Investors 

Simon Whittington - IR and Corporate Development Director

+44 (0) 77 1137 2928

Media

Headland PZCussons@headlandconsultancy.com

+44 (0) 20 3805 4822

Susanna Voyle, Charlie Twigg

About PZ Cussons

 

PZ Cussons is a listed consumer goods business headquartered in Manchester, UK, employing 2,000 people internationally. Since our founding in 1884, we have been creating products to delight, care for and nourish consumers. We are focused on our lead markets of the UK, ANZ, Nigeria and Indonesia across the core categories of Personal, Home and Baby Care. Our locally-loved brands include Carex, Childs Farm, Cussons Baby, Imperial Leather, Morning Fresh, Original Source, Premier, Sanctuary Spa, Stella and St.Tropez. Sustainability and the wellbeing of our employees and communities everywhere are core to what we do and captured by our purpose: For Everyone. For Life. For Good.

 

Cautionary note regarding forward-looking statements

 

This announcement contains certain forward-looking statements relating to expected or anticipated results, performance or events. Such statements are subject to normal risks associated with the uncertainties in our business, supply chain and consumer demand along with risks associated with macro-economic, political and social factors in the markets in which we operate. Whilst we believe that the expectations reflected herein are reasonable based on the information we have as at the date of this announcement, actual outcomes may vary significantly owing to factors outside the control of the Group, such as cost of materials or demand for our products, or within our control such as our investment decisions, allocation of resources or changes to our plans or strategy. The Group expressly disclaims any obligation to revise forward-looking statements made in this or other announcements to reflect changes in our expectations or circumstances. No reliance may be placed on the forward-looking statements contained within this announcement.


[1] Including cash held in Nigeria. Further detail on the breakdown of cash will be provided as part of the full year results announcement

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUAUQUPQGMQ
Date   Source Headline
30th Jun 20232:18 pmRNSDirector/PDMR Shareholding
29th Jun 202311:06 amRNSDirector/PDMR Shareholding
27th Jun 20237:00 amRNSTrading Statement
21st Jun 20239:59 amRNSDirector/PDMR Shareholding
16th Jun 20237:00 amRNSDirectorate Change
19th May 20239:27 amRNSDirector/PDMR Shareholding
21st Apr 20239:00 amRNSIntention to Conduct Audit Tender
19th Apr 202310:01 amRNSDirector/PDMR Shareholding
13th Apr 20233:18 pmRNSHolding(s) in Company
13th Apr 20237:00 amRNSQ3 Trading Update
12th Apr 20232:18 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSDirectorate Change
21st Mar 20239:30 amRNSDirector/PDMR Shareholding
17th Mar 20234:35 pmRNSPrice Monitoring Extension
21st Feb 20239:31 amRNSDirector/PDMR Shareholding
8th Feb 20237:00 amRNS2023 Interim Results
19th Jan 20234:20 pmRNSDirector/PDMR Shareholding
20th Dec 20222:40 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:55 pmRNSDirector/PDMR Shareholding
24th Nov 20223:24 pmRNSResult of AGM
24th Nov 20227:00 amRNSDirectorate Change
21st Nov 20223:21 pmRNSDirector/PDMR Shareholding
14th Nov 20227:00 amRNSNew Credit Facility Linked to B Corp Ambitions
18th Oct 20223:52 pmRNSDirector/PDMR Shareholding
14th Oct 20227:00 amRNSPublication of Annual Report and Notice of AGM
27th Sep 202210:52 amRNSDirector/PDMR Shareholding
23rd Sep 20223:04 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNS2022 Full Year Results
21st Sep 202210:06 amRNSDirector Declaration
2nd Sep 202210:29 amRNSHolding(s) in Company
19th Aug 202210:05 amRNSDirector/PDMR Shareholding
29th Jul 20229:46 amRNSDirector/PDMR Shareholding
20th Jul 20223:21 pmRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSTrading update
21st Jun 20224:10 pmRNSDirector/PDMR Shareholding
20th May 202210:30 amRNSFurther re 2021 AGM voting results
19th May 20225:45 pmRNSDirector/PDMR Shareholding
21st Apr 202210:30 amRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSTrading Statement
1st Apr 20229:00 amRNSDirector/PDMR Shareholding
25th Mar 202210:00 amRNSDirector/PDMR Shareholding
23rd Mar 20229:00 amRNSDirector/PDMR Shareholding
21st Mar 202210:15 amRNSDirector/PDMR Shareholding
21st Mar 20227:00 amRNSAcquisition of Childs Farm
21st Feb 202211:00 amRNSDirector/PDMR Shareholding
11th Feb 20229:25 amRNSDirector/PDMR Shareholding
11th Feb 20229:15 amRNSBoard update
9th Feb 20227:00 amRNSHalf-year Report
19th Jan 202210:10 amRNSDirector/PDMR Shareholding
20th Dec 20214:35 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.